Soufir JC, Mieusset R. Male contraception. Paris: Springer; 2013.
Soufir JC. Male contraception: a feasible option today? Med Reprod Gynecol Endocrinol. 2013;15:52–63.
Schearer SB, Alvarez-Sanchez F, Anselmo J, Brenner P, Couthino E, Latham-Faundes A, et al. Hormonal contraception for men. In: Hansson V, Ritzen M, Purvis K, French FS, editors. Endocrine approach to male contraception. Copenhagen: Scriptor; 1978. p. 680–712.
Salat-Baroux J, Le Lorier G, Sakiz E, Rotman J, Piquet JM. Preliminary trials of an oral chemical contraceptive for men. J Gynecol Obstet Biol Reprod (Paris). 1976;5:831–42.
Kinniburgh D, Anderson RA, Baird DT. Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride. J Androl. 2001;22(1):88–95.
Kinniburgh D, Zhu H, Cheng L, Kicman AT, Baird DT, Anderson RA. Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men. Hum Reprod. 2002;17(6):1490–501.
Anderson RA, Van Der Spuy ZM, Dada OA, Tregoning SK, Zinn PM, Adeniji OA, Fakoya TA, Smith KB, Baird DT. Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone. Hum Reprod. 2002;17(11):2869–77.
Anderson RA, Kinniburgh D, Baird DT. Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception. J Clin Endocrinol Metab. 2002;87(8):3640–9.
Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab. 1996;81(11):4113–21.
Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan RI, Handelsman DJ. Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab. 2003;88(10):4659–67.
Valette G, Cavier R. A physiologic test usable for the study of the absorption rate of a drug. C R Seances Soc Biol Fil. 1950;144:825–7.
Jayle MF. Value of percutaneous administration in hormone therapy. Concours Med. 1951;73:1671–5.
Mauvais-Jarvis P, Bercovici JP. Hormone therapy by percutaneous route. Physiological bases. Clinical application. Therapeutique. 1972;48:403–6.
Bercovici JP, Mauvais-Jarvis P. Physiological basis of steroid hormone therapy by percutaneous approach. Presse Med. 1971;79:1675–8.
Schaison G, Nahoul K, Couzinet B. Percutaneous dihydrotestosterone (DHT) treatment In: Nieschlag E, Behre HM, editors. Testosterone : Action.Deficiency. Substitution. Berlin Heidelberg: Spinger-Verlag; 1990. p. 155–64.
Choi SK, Han SW, Kim DH, de Lignieres B. Transdermal dihydrotestosterone therapy and its effects on patients with microphallus. J Urol. 1993;150:657–60.
Dictionnaire VIDAL. Percutacrine androgénique forte. 1976. p. 1285.
Soufir JC, Jouannet P, Soumah A, Marson J. Sperm production and gonadotrophin secretion in men: reversible inhibition. Nouv Presse Med. 1982;15:1145.
Soufir JC, Jouannet P, Marson J, Soumah A. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Acta Endocrinol (Copenh). 1983;102:625–32.
Soufir JC, Jouannet P, Soumah A. Male contraception: effect on sperm production and gonadotrophin secretion of percutaneous testosterone alone or combined with oral medroxyprogesterone acetate. Manchester: Society for Study of Fertility; 1983.
Soufir JC, Laporte A. Efficiency of a male contraceptive association-oral medroxyprogesterone acetate-percutaneous testosterone. Florence: IVth International Congress of Andrology; 1989. p. 14.
Soufir JC, Meduri G, Ziyyat A. Spermatogenetic inhibition in men taking a combination of oral medroxyprogesterone acetate and percutaneous testosterone as a male contraceptive method. Hum Reprod. 2011;26:1708–14.
Aaltonen P, Amory JK, Anderson RA, et al. 10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception. J Androl. 2007;28:362–3.
Delanoe D, Fougeyrollas B, Meyer L, Thonneau P. Androgenisation of female partners of men on medroxyprogesterone acetate percutaneous testosterone contraception. Lancet. 1984;1(8371):276.
Guérin JF, Rollet J. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens. Int J Androl. 1988;11:187–99.
Lobel B, Olivo JF, Guille F, Le Lannou D. Contraception in men: efficacy and immediate toxicity. A study of 18 cases. Acta Urol Belg. 1989;57:117–24.
Bouchard P, Garcia E. Influence of testosterone substitution on sperm suppression by LHRH agonists. Horm Res. 1987;28:175–80.
Pöllänen P, Nikkanen V, Huhtaniemi I. Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception. Int J Androl. 2001;24:369–80.
Büchter D, von Eckardstein S, von Eckardstein A, Kamischke A, Simoni M, Behre HM, Nieschlag E. Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab. 1999;84:1244–9.
Hair WM, Kitteridge K, O’Connor DB, Wu FC. A novel male contraceptive pill-patch combination: oral desogestrel and transdermal testosterone in the suppression of spermatogenesis in normal men. J Clin Endocrinol Metab. 2001;86:5201–9.
Gonzalo IT, Swerdloff RS, Nelson AL, Clevenger B, Garcia R, Berman N, et al. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. J Clin Endocrinol Metab. 2002;87:3562–72.
Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM, et al. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. J Clin Endocrinol Metab. 2006;91:4374–80.
Roth MY, Shih G, Ilani N, Wang C, Page ST, Bremner WJ, et al. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial. Contraception. 2014;90:407–12.
Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, et al. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido. J Clin Endocrinol Metab. 1991;73:1360–9.
Ilani N, Roth MY, Amory JK, Swerdloff RS, Dart C, Page ST, et al. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. J Clin Endocrinol Metab. 2012;97:3476–86.
Wallace EM, Gow SM, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study I: plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol and inhibin concentrations. J Clin Endocrinol Metab. 1993;77:290–3.
Handelsman DJ, Farley TM, Peregoudov A, Waites GM. Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. Fertil Steril. 1995;63:125–33.
Wang C, Berman NG, Veldhuis JD, Der T, McDonald V, Steiner B, et al. Graded testosterone infusions distinguish gonadotropin negative-feedback responsiveness in Asian and white men--a Clinical Research Center study. J Clin Endocrinol Metab. 1998;83:870–6.
Amory JK, Anawalt BD, Matsumoto AM, Bremner WJ. Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development. J Androl. 2001;22:1053–60.
McLachlan RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD, et al. Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment. J Clin Endocrinol Metab. 2004;89:142–9.
Anderson RA, Wallace AM, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5a-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. J Clin Endocrinol Metab. 1996;81:902–8.
Hikim AP, Wang C, Lue Y, Johnson L, Wang XH, Swerdloff RS. Spontaneous germ cell apoptosis in humans: evidence for ethnic differences in the susceptibility of germ cells to programmed cell death. J Clin Endocrinol Metab. 1998;83:152–6.
Amory JK, Page ST, Anawalt BD, Coviello AD, Matsumoto AM, Bremner WJ. Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception. J Androl. 2007;28:548–54.
Gu YQ, Wang XH, Xu D, Peng L, Cheng LF, Huang MK, et al. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab. 2003;88:562–8.
Kornmann B, Nieschlag E, Zitzmann M, Gromoll J, Simoni M, von Eckardstein S. Body fat content and testosterone pharmacokinetics determine gonadotropin suppression after intramuscular injections of testosterone preparations in normal men. J Androl. 2009;30:602–13.
McLachlan RI, O’Donnell L, Stanton PG, Balourdos G, Frydenberg M, de Kretser DM, et al. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men. J Clin Endocrinol Metab. 2002;87:546–56.
Meriggiola MC, Costantino A, Bremner WJ, Morselli-Labate AM. Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen. J Androl. 2002;23:684–90.
Salimtschik M, Mouridsen HT, Loeber J, Johansson E. Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes. Cancer Chemother Pharmacol. 1980;4:267–9.
Schaison G, Renoir M, Lagoguey M, Mowszowicz I. On the role of dihydrotestosterone in regulating luteinizing hormone secretion in man. J Clin Endocrinol Metab. 1980;5:1133–7.
Couzinet B, Young J, Brailly S, Chanson P, Thomas JL, Schaison G. The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor. J Clin Endocrinol Metab. 1996;81:4218–23.
World Health Organization. Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet. 1990;336:955–9.
World Health Organization. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril. 1996;65:821–9.
Nieschlag E, Zitzmann M, Kamischke A. Use of progestins in male contraception. Steroids. 2003;68(10-13):965–72.
Ilani N, Liu PY, Swerdloff RS, Wang C. Does ethnicity matter in male hormonal contraceptive efficacy? Asian J Androl. 2011;13(4):579–84.
Santner SJ, Albertson B, Zhang GY, Zhang GH, Santulli M, Wang C, et al. Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects. J Clin Endocrinol Metab. 1998;83(6):2104–9.
Cui YM, Wang ZN, Chen XW, Zhang HL, Zhao X, Zhou Y. Pharmacokinetics and pharmacodynamics of single and multiple doses of prasugrel in healthy native Chinese subjects. Acta Pharmacol Sin. 2012;33(11):1395–400.
Es-slami S, Marmor D, Soufir JC. Genetic lesions in male gametes and cytotoxic treatments. Prevention by hormonal inhibition of spermatogenesis. In: Hamamah S, Mieusset R, Hamamah S, Mieusset R, editors. Research in male gametes: production and quality. Paris: Inserm; 1996. p. 97–107.
Velez de la Calle JF, Soufir JC, Chodorge F, Boisseau C, Kercret H, Jégou B. Reproductive effects of the anti-cancer drug procarbazine in male rats at different ages. J Reprod Fertil. 1988;84:51–61.
Velez de la Calle JF, Jégou B. Protection by steroid contraceptives against procarbazine-induced sterility and genotoxicity in male rats. Cancer Res. 1990;50:1308–15.
Dulioust E, Radigue C, Velez de la Calle JF, Jégou B, Soufir JC, Auroux M. Cytostatic treatment of the male rat: effects on offspring and protection by initial hormonal treatment. C R Acad Sci III. 1989;309:137–42.
Jégou B, Velez de la Calle JF, Bauché F. Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring. Proc Natl Acad Sci U S A. 1991;88:8710–4.
Es-slami S, Charcellay S, Pinon-Lataillade G, Soufir JC. Short term pretreatment with medroxyprogesterone and testosterone may potentiate irradiation damage to spermatogenesis in rats. Cancer. 1999;85:1313–22.
Meistrich ML, Finch M, da Cunha MF, Hacker U, Au WW. Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res. 1982;42(1):122–31.
da Cunha MF, Meistrich ML, Nader S. Absence of testicular protection by a gonadotropin-releasing hormone analogue against cyclophosphamide-induced testicular cytotoxicity in the mouse. Cancer Res. 1987;47(4):1093–7.
Shetty G, Weng CC, Meachem SJ, Bolden-Tiller OU, Zhang Z, Pakarinen P, et al. Both testosterone and follicle-stimulating hormone independently inhibit spermatogonial differentiation in irradiated rats. Endocrinology. 2006;147(1):472–82.
Porter KL, Shetty G, Meistrich ML. Testicular edema is associated with spermatogonial arrest in irradiated rats. Endocrinology. 2006;147(3):1297–305.
Shetty G, Zhou W, Weng CC, Shao SH, Meistrich ML. Leydig cells contribute to the inhibition of spermatogonial differentiation after irradiation of the rat. Andrology. 2016;4(3):412–24.
Shetty G, Wilson G, Hardy MP, Niu E, Huhtaniemi I, Meistrich ML. Inhibition of recovery of spermatogenesis in irradiated rats by different androgens. Endocrinology. 2002;143(9):3385–9.
Meistrich ML, Wilson G, Shuttlesworth G, Huhtaniemi I, Reissmann T. GnRH agonists and antagonists stimulate recovery of fertility in irradiated LBNF1 rats. J Androl. 2001;22(5):809–17.
Meistrich ML, Shetty G. Hormonal suppression for fertility preservation in males and females. Reproduction. 2008;136(6):691–701.
Shetty G, Weng CC, Bolden-Tiller OU, Huhtaniemi I, Handelsman DJ, Meistrich ML. Effects of medroxyprogesterone and estradiol on the recovery of spermatogenesis in irradiated rats. Endocrinology. 2004;145(10):4461–9.
Porter KL, Shetty G, Shuttlesworth GA, Weng CC, Huhtaniemi I, Pakarinen P, Meistrich ML. Estrogen enhances recovery from radiation-induced spermatogonial arrest in rat testes. J Androl. 2009;30(4):440–51.
Soufir JC, Dantec MC, Jégou B, Folliot R, Garnier DH, Andre J, et al. Epididymal effects of gossypol. Lancet. 1984;2(8394):107.
Soufir JC, Radigue C, Dantec MC, Garnier D, Jégou B. Gossypol-induced modifications in the microenvironment of rat epididymal spermatozoa. J Reprod Fertil. 1989;86:427–34.
Radigue C, Soufir JC, Couvillers ML, Dantec MC, Folliot R. Early effects of gossypol on the testis and epididymis in the rat. Reprod Nutr Dev. 1988;28:1329–38.
Waites GM, Wang C, Griffin PD. Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug. Int J Androl. 1998;21:8–12.
Pointis G, Radigue C, Rao B, Jégou B, Poisson JE, Soufir JC. Dual effect of gossypol on Leydig cells. Florence: IVth International Congress of Andrology; 1989.
Druez D, Marano F, Calvayrac R, Volochine B, Soufir JC. Effect of gossypol on the morphology, motility and metabolism of a flagellated protist, Dunaliella bioculata. J Submicrosc Cytol Pathol. 1989;21:367–74.
MacLeod J, Hotchkiss RS. The effect of hyperpyrexia upon spermatozoa counts in men. Endocrinology. 1941;28:780–4.
Watanabe A. The effect of heat on human spermatogenesis. Kyushu J Med Sci. 1959;10:101–17.
Robinson D, Rock J, Menkin MF. Control of human spermatogenesis by induced changes of intrascrotal temperature. J Am Med Ass. 1968;204:80–7.
Rock J, Robinson D. Effect of induced intrascrotal hyperthermia on testicular function in man. Am J Obstet Gynec. 1965;93:793–801.
Shafik A. Testicular suspension as a method of male contraception: technique and results. Adv Contr Deliv Syst. 1991;VII:269–79.
Procope BJ. Effect of repeated increase of body temperature on human sperm cells. Int J Fertil. 1965;10:333–9.
Brown-Woodman PDC, Post EJ, Gasc GC, White IG. The effect of a single sauna exposure on spermatozoa. Arch Androl. 1984;12:9–15.
Wang C, Cui Y, Wang X-H, Jia Y, Sinha Hikim A, Lue Y-H, et al. Transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis. J Clin Endocrinol Metab. 2007;92:3292–304.
Zhu H, Cui Y, Xie J, Chen L, Chen X, Guo X, et al. Proteomic analysis of testis biopsies in men treated with transient scrotal hyperthermia reveals the potential targets for contraceptive development. Proteomics. 2010;10:3480–93.
Rao M, Zhao X-L, Yang J, Hu S-F, Lei H, Xia W, et al. Effect of transient scrotal hyperthermia on sperm parameters, seminal plasma biochemical markers, and oxidative stress in men. Asian J Androl. 2015;17:668–75.
French DJ, Leeb CS, Fahrion SL, Law OT, Jecht EW. Self-induced intrascrotal hyperthermia in man followed by decrease in sperm count. A preliminary report. Andrologie. 1973;5:201–5.
Robinson D, Rock J. Intrascrotal hyperthermia induced by scrotal insulation: effect on spermatogenesis. Obstet Gynecol. 1967;2:217–23.
Wang C, McDonald V, Leung A, Superlano L, Berman N, Hull L, et al. Effect of increased scrotal temperature on sperm production in normal men. Fertil Steril. 1997;68(2):334–9.
Mieusset R, Grandjean H, Mansat A, Pontonnier F. Inhibiting effect of artificial cryptorchidism on spermatogenesis. Fertil Steril. 1985;43:589–94.
Mieusset R, Bujan L, Mansat A, Pontonnier F, Grandjean H. Hyperthermia and human spermatogenesis: enhancement of the inhibitory effect obtained by ‘artificial cryptorchidism’. Int J Androl. 1987;10:571–80.
Shafik A. Contraceptive efficacy of polyester-induced azoospermia in normal men. Contraception. 1992;45:439–51.
Moeloek N. Polyester sling scrotal cover induces oligozoospermia in normal Indonesian men. Med J Indones. 1995;4:225–30.
Ahmad G, Moinard N, Lamare C, Mieusset R, Bujan L. Mild testicular and epididymal hyperthermia alters sperm chromatin integrity in men. Fertil Steril. 2012;97:546–53.
Mieusset R, Bujan L, Mansat A, Pontonnier F, Grandjean H. Effect of artificial cryptorchidism on sperm morphology. Fertil Steril. 1987;47:150–5.
Kitayama T. Study on testicular temperature in man. Acta Urol Jap. 1965;11:435–7.
Fukui N. Action of body temperature on the testicle. Japan Med World. 1923;3:160–7.
Frankenhuis MT, Wensing CJ. Induction of spermatogenesis in the naturally cryptorchid pig. Fertil Steril. 1979;31:428–33.
Shafik A. Three new methods for male contraception. Asian J Androl. 1999;1:161–7.
Bengoudifa B, Mieusset R. Thermal asymmetry of the human scrotum. Hum Reprod. 2007;22:2178–82.
Liu Y-X. Temperature control of spermatogenesis and prospect of male contraception. Front Biosci. 2010;2:730–55.
Kim B, Park K, Rhee K. Heat stress response of male germ cells. Cell Mol Life Sci. 2013;70:2623–36.
Durairajanayagam D, Agarwal A, Ong C. Causes, effects and molecular mechanisms of testicular heat stress. Reprod BioMed Online. 2015;30:14–27.
Mieusset R, Bujan L. The potential of mild testicular heating as a safe, effective and reversible contraceptive method for men. Int J Androl. 1994;17:186–91.
Lue Y-H, Hikim AP, Swerdloff RS, Im P, Taing K, Bui T, et al. Single exposure to heat induces stage-specific germ cell apoptosis in rats: role of intratesticular testosterone on stage specificity. Endocrinology. 1999;140:1709–17.
Lue Y-H, Lasley BL, Laughlin LS, Swerdloff RS, Hikim AP, Leung A, et al. Mild testicular hyperthermia induces profound transitional spermatogenic suppression through increased germ cell apoptosis in adult cynomolgus monkeys (Macaca fascicularis). J Androl. 2002;23:799–805.
Carlsen E, Andersson AM, Petersen JH, Skakkebaek NE. History of febrile illness and variation in semen quality. Hum Reprod. 2003;18:2089–92.
Shafik A, Ibrahim IH, El-Sayed EM. Effect of different types of textile fabric on spermatogenesis: electrostatic potentials generated on the surface of the human scrotum by wearing different types of fabric. Arch Androl. 1992;29:147–50.
Shafik A. Effect of different types of textiles on male sexual activity. Arch Androl. 1996;37:111–5.
Mieusset R, Quintana Casares PI, Sanchez-Partida LG, Sowerbutts SF, Zupp JL, Setchell BP. The effects of moderate heating of the testes and epididymides of rams by scrotal insulation on body temperature, respiratory rate, spermatozoa output and motility, and on fertility and embryonic survival in ewes inseminated with frozen semen. Ann N Y Acad Sci. 1991;637:445–58.
Mieusset R, Quintana Casares P, Sanchez Partida LG, Sowerbutts SF, Zupp JL, Setchell BP. Effects of heating the testes and epididymides of rams by scrotal insulation on fertility and embryonic mortality in ewes inseminated with frozen semen. J Reprod Fertil. 1992;94:337–43.
Serfaty D, Sitruk-Ware R, Wang C, Nieschlag E. The Paris Manifesto: It’s time for new male contraceptives. J Gynecol Obstet Biol Reprod (Paris). 2016;45(8):990–1.